Scott D Ramsey, Richard J Willke, Henry Glick, Shelby D Reed, Federico Augustovski, Bengt Jonsson, Andrew Briggs, Sean D Sullivan
Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the economic value of these interventions. The growing number of prospective clinical/economic trials reflects both widespread interest in economic information for new technologies and the regulatory and reimbursement requirements of many countries that now consider evidence of economic value along with clinical efficacy. As decision makers increasingly demand evidence of economic value for health care interventions, conducting high-quality economic analyses alongside clinical studies is desirable because they broaden the scope of information available on a particular intervention, and can efficiently provide timely information with high internal and, when designed and analyzed properly, reasonable external validity...
March 2015: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research